bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
The DOI matches its Crossref record.
Abstract
To ensure that the mature T cell repertoire is MHC-restricted yet not autoreactive, cortical thymocytes that express low levels of the TCR/CD3 complex along with CD4 and CD8 (double positive cells) are subjected to positive and negative selection. Surviving cells lose either CD4 or CD8 (single positive cells) and are located primarily in the thymic medulla. bcl-2, a novel proto-oncogene that promotes cell survival by inhibiting programmed cell death (apoptosis), may be an important protein in regulating cell survival during thymocyte development. We have examined the expression of bcl-2 during T cell development by using human thymocytes. Consistent with previous studies, human thymic tissue sections stained for bcl-2 revealed occasional bcl-2+ cells within the thymic cortex and intense staining of virtually all medullary thymocytes. More quantitative western blot analysis and S1 nuclease protection assay revealed that single positive thymocytes contained approximately 2 to 3 times the level of bcl-2 protein and 3 to 4 times the level of bcl-2 mRNA as double positive thymocytes. Flow cytometric analysis of purified double positive thymocytes revealed that minimal amounts of bcl-2 protein was in fact detectable in most cells, although a small subpopulation (10-20%) contained higher levels. In contrast, brighter staining for bcl-2 was observed in virtually all single positive thymocytes. Surprisingly, CD4-CD8- thymocytes (both CD3- and CD3+) expressed the same amount of bcl-2 as did the single positive thymocytes. Because a large percentage of CD3-CD4-CD8- cells are cycling, we examined the effect of mitogenic stimulation on bcl-2 expression by double positive thymocytes by using western blot analysis. bcl-2 expression in double positive thymocytes could not be induced by cell cycle entry following stimulation with PMA and ionomycin. Our data demonstrate that bcl-2 expression is biphasic during T cell development. Both CD3-CD4-CD8- and CD3+CD4+ and CD3+CD8+ thymocytes express high levels of bcl-2. Therefore, diminished bcl-2 expression in double positive thymocytes seems to be the result of specific down-regulation in order to facilitate the selection CD4+CD8+ thymocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
BCL-2 FAMILY: Regulators of Cell Death
Chao, D. T., & Korsmeyer, S. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.395 · Cited by 1,685
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616
Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice
Akashi, K., Kondo, M., von Freeden-Jeffry, U., Murray, R., & Weissman, I. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80291-3 · Cited by 593
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584
“Bcl-2 is shown to be expressed in peripheral T cells, CD4 (1), CD8(1), and CD4(2)CD8(2) thymocytes, but not in CD4 (1)CD8(1) thymocytes, which are exposed to the programmed cell death under negative selection of T cell development (48, 49).”
BackgroundDynamic regulation of miRNA expression in ordered stages of cellular development
Neilson, J. R., Zheng, G. X. Y., Burge, C. B., & Sharp, P. A. (2007) · Genes & Development · doi:10.1101/gad.1522907 · Cited by 471
Development and Selection of T Cells: Facts and Puzzles
Kisielow, P., & Von Boehmer, H. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60620-3 · Cited by 444
Apoptosis as a therapeutic tool in rheumatoid arthritis
Pope, R. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri846 · Cited by 401
Glucocorticoids in T cell apoptosis and function
Herold, M. J., McPherson, K. G., & Reichardt, H. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5390-y · Cited by 397
Bcl-XL and Bcl-2 repress a common pathway of cell death.
Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B., & Korsmeyer, S. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.821 · Cited by 395
Cell biology of IL-7, a key lymphotrophin
Jiang, Q., Li, W. Q., Aiello, F. B., Mazzucchelli, R., Asefa, B., Khaled, A. R., & Durum, S. K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.004 · Cited by 342
von Freeden-Jeffry, U., Solvason, N., Howard, M., & Murray, R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80517-8 · Cited by 332
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.
Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J., & Nuñez, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06307.x · Cited by 301
Self-citationYang, T., Kozopas, K. M., & Craig, R. W. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.6.1173 · Cited by 299
Roles of Zinc Signaling in the Immune System
Hojyo, S., & Fukada, T. (2016) · Journal of Immunology Research · doi:10.1155/2016/6762343 · Cited by 294
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Merino, D., Kelly, G. L., Lessene, G., Wei, A. H., Roberts, A. W., & Strasser, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.004 · Cited by 287
Suzuki, S., Enosawa, S., Kakefuda, T., Shinomiya, T., Amari, M., Naoe, S., Hoshino, Y., & Chiba, K. (1996) · Transplantation · doi:10.1097/00007890-199601270-00006 · Cited by 283
Chonghaile, T. N., Roderick, J. E., Glenfield, C., Ryan, J., Sallan, S. E., Silverman, L. B., Loh, M. L., Hunger, S. P., Wood, B., DeAngelo, D. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0353 · Cited by 275
Delgado-Martin, C., Meyer, L. K., Huang, B. J., Shimano, K. A., Zinter, M. S., Nguyen, J. V., Smith, G. A., Taunton, J., Winter, S. S., Roderick, J. R., et al. (2017) · Leukemia · doi:10.1038/leu.2017.136 · Cited by 133
Samten, B., Howard, S. T., Weis, S. E., Wu, S., Shams, H., Townsend, J. C., Safi, H., & Barnes, P. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6357 · Cited by 41
Metadata
- Authors
- Gratiot-Deans, J., Ding, L., Turka, L. A., & Nuñez, G.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-07-01
- Volume
- 151
- Issue
- 1
- Pages
- 83-91
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1524516556
- Cited by
- 135
- References
- 0
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.